Recruitment for Phase III clinical trials to assess the efficacy and safety of bepirovirsen is also underway, with results expected in early 2026 (NCT05630807 and NCT05630820)
Draw 75 units of air into your syringe
Human drug compounding
The peptide contains four proline residues, including an unusual triple-proline sequence that gives it exceptional structural stability
clinicaltrials.gov PeptideStack page context: visitors can use the header navigation to reach the product catalog, blog, calculators, supplier pages, discount-code pages, contact page, legal policies, shipping policy, refund policy, privacy policy, terms, and research disclaimer